Biohaven Pharmaceutical Q2 EPS $(3.82) Down From $(2.62) YoY

Biohaven Pharmaceutical (NYSE:BHVN) reported quarterly losses of $(3.82) per share. This is a 45.8 percent decrease over losses of $(2.62) per share from the same period last year.